Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Pharmaceuticals (Basel, Switzerland)
|
June 2, 2021
Deregulation of the Interleukin-7 Signaling Pathway in Lymphoid Malignancies
Inge Lodewijckx, Jan Cools
Hemasphere
|
September 3, 2021
Oncogenic Cooperation Between IL7R-JAK-STAT Pathway Mutations
Inge Lodewijckx, Nicole Mentens, Kris Jacobs, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association
|
June 5, 2024
Potential therapeutic effect of a ketogenic diet for the treatment of lymphoedema: Results of an exploratory study
Inge Lodewijckx, Christophe Matthys, Joke Verheijen, et al.
Science Translational Medicine
|
April 14, 2017
Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation
Elizabeth Allen, Arnaud Jabouille, Lee B Rivera, et al.
Science Translational Medicine
|
May 31, 2019
Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition
Roger A Habets, Charles E de Bock, Lutgarde Serneels, et al.
Blood
|
September 8, 2019
Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia
Michael Broux, Cristina Prieto, Sofie Demeyer, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Pharmaceuticals (Basel, Switzerland)
|
June 2, 2021
Deregulation of the Interleukin-7 Signaling Pathway in Lymphoid Malignancies
Inge Lodewijckx, Jan Cools
Hemasphere
|
September 3, 2021
Oncogenic Cooperation Between IL7R-JAK-STAT Pathway Mutations
Inge Lodewijckx, Nicole Mentens, Kris Jacobs, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association
|
June 5, 2024
Potential therapeutic effect of a ketogenic diet for the treatment of lymphoedema: Results of an exploratory study
Inge Lodewijckx, Christophe Matthys, Joke Verheijen, et al.
Science Translational Medicine
|
April 14, 2017
Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation
Elizabeth Allen, Arnaud Jabouille, Lee B Rivera, et al.
Science Translational Medicine
|
May 31, 2019
Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition
Roger A Habets, Charles E de Bock, Lutgarde Serneels, et al.
Blood
|
September 8, 2019
Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia
Michael Broux, Cristina Prieto, Sofie Demeyer, et al.
Page
of 1